+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The tag Nimotuzumab returned 0 results.

No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.

Nimotuzumab is a monoclonal antibody used in the treatment of skin cancer. It is used to treat squamous cell carcinoma, a type of skin cancer that affects the outer layer of the skin. Nimotuzumab works by targeting a protein called epidermal growth factor receptor (EGFR), which is found on the surface of cancer cells. This protein helps cancer cells to grow and spread. By targeting this protein, Nimotuzumab can help to slow down or stop the growth of cancer cells. Nimotuzumab is administered intravenously and is usually given in combination with other treatments such as chemotherapy or radiation therapy. It is generally well tolerated and has few side effects. It is approved for use in several countries, including India, Mexico, and China. Nimotuzumab is a promising treatment for skin cancer and is being studied in clinical trials for other types of cancer. It is also being studied as a potential treatment for other diseases such as Alzheimer's disease and Parkinson's disease. Some companies in the Nimotuzumab market include Biocon, Cipla, and Intas Pharmaceuticals. Show Less Read more